The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.

Mediators of Inflammation
R Masekela, R J Green

Abstract

Non-cystic fibrosis-related bronchiectasis is a chronic inflammatory lung disease, which is regarded as an "orphan" lung disease, with little research devoted to the study of this condition. Bronchiectasis results in impaired quality of life and mortality if left untreated. The tools available in the armamentarium for the management of bronchiectasis entail antibiotic therapy traditionally used to treat exacerbations, stratagems to improve mucociliary clearance, and avoidance of toxins. Macrolides have been known for the last two decades to have not only anti-bacterial effects but immunomodulatory properties as well. In cystic fibrosis, the use of macrolides is well documented in subjects colonized with Pseudomonas aeruginosa, to improve quality of life and lung function. There is currently emerging evidence to suggest the benefit of macrolides in subjects not colonized with Pseudomonas aeruginosa. This beneficial effect has been less explored in the context of bronchiectasis from other causes. The purpose of this paper is to review the current literature on the use of macrolides in non-cystic fibrosis related bronchiectasis in paediatrics.

References

Jan 1, 1991·Respiration; International Review of Thoracic Diseases·H NagaiA Kurashima
May 28, 1994·Annals of the New York Academy of Sciences·J EllerP J Cole
Apr 1, 1993·Respiratory Medicine·J TredanielA Hirsch
Jul 1, 1997·American Journal of Respiratory and Critical Care Medicine·H TakizawaK Ito
Aug 1, 1997·Respiratory Medicine·O SäynäjäkangasS L Kivelä
Mar 28, 1998·American Journal of Respiratory and Critical Care Medicine·M MikamiR A Stockley
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·S KudohM Ando
Mar 5, 1999·The European Respiratory Journal·K W TsangE Tanaka
Dec 10, 1999·The Astrophysical Journal·I YamamuraS T Ridgway
Jan 25, 2000·American Journal of Physiology. Cell Physiology·L PaolucciE Rozengurt
Feb 12, 2000·Chest·K W TsangW Lam
Feb 24, 2000·Pediatric Pulmonology·R SingletonC Lewis
Jul 4, 2001·Advances in Immunology·S Akira
Oct 31, 2001·Journal of Thoracic Imaging·N A Kothari, S S Kramer
Nov 6, 2001·American Journal of Respiratory Cell and Molecular Biology·M GorriniM Luisetti
Aug 9, 2002·The European Respiratory Journal·L ZhengK W Tsang
Aug 15, 2002·The Medical Journal of Australia·Anne B ChangUNKNOWN Working Group on Indigenous Paediatric Respiratory Health
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Nada AldallalDwight C Look
Nov 16, 2002·American Journal of Respiratory and Critical Care Medicine·Kenneth N OlivierUNKNOWN Nontuberculous Mycobacteria in Cystic Fibrosis Study Group
Jun 28, 2003·Blood·Fumitaka HayashiAndrew D Luster
Apr 1, 1962·Diseases of the Chest·M D ALTSCHULE
Jul 1, 1962·Diseases of the Chest·G C GRIFFITH
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Lisa SaimanUNKNOWN Macrolide Study Group
May 18, 2004·Anaesthesia·P C W Beatty, S F Beatty
Aug 3, 2004·Nature Reviews. Immunology·William C ParksYolanda S López-Boado
Feb 8, 2005·American Journal of Respiratory and Critical Care Medicine·Clifford C TaggartNoel G McElvaney
Mar 3, 2005·Thorax·K W TsangM Chan-Yeung
Apr 9, 2005·Treatments in Respiratory Medicine·Alicia A CymbalaGuy W Amsden
May 6, 2005·Archives of Disease in Childhood·J TwissC Byrnes
May 14, 2005·Journal of Tropical Pediatrics·Deniz DoğruAyse Tana Aslan
Jun 9, 2005·Respiration; International Review of Thoracic Diseases·B KaradagE Dagli
Jan 26, 2006·Respiratory Medicine·Miguel A Martínez-GarcíaJuan Jose Soler-Cataluña
Feb 16, 2006·Journal of Clinical Pharmacy and Therapeutics·E YalçinA Göçmen
Apr 8, 2006·Thorax·A TorregoK F Chung
Apr 21, 2006·The Cochrane Database of Systematic Reviews·P Wills, M Greenstone

❮ Previous
Next ❯

Citations

Jun 26, 2013·American Journal of Respiratory and Critical Care Medicine·Michael R KnowlesMargaret W Leigh
Oct 10, 2013·Pediatric Surgery International·Cristiano Feijó AndradeJosé Carlos Felicetii
Oct 11, 2014·Respiratory Medicine·Charles S HaworthJ Stuart Elborn
Aug 16, 2016·Clinics in Chest Medicine·Michael R KnowlesMargaret Leigh
Sep 19, 2017·Pediatric Pulmonology·Kim M HareKeith Grimwood
Oct 26, 2018·Expert Opinion on Pharmacotherapy·Maria Gabriella MateraMario Cazzola
Apr 7, 2020·Expert Review of Respiratory Medicine·Manisha RamphulJayesh Mahendra Bhatt
Jun 15, 2017·Frontiers in Pediatrics·Susan J PizzuttoJohn W Upham
Mar 30, 2021·ERJ Open Research·Cristina Ardura-GarciaMarielle W Pijnenburg

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.